Report ID: SQMIG35J2030
Infectious Disease Therapeutics Market Size, Share, Growth Analysis, By Mode of treatment(Vaccines and drugs), By Target organism (Antiviral, antifungal, antibacterial, anti-parasite), By Infection type(Parasitic, viral, fungal, bacterial), By Distribution channel(Hospitals, clinics, and others), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35J2030 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
119 |
Figures:
77
Infectious Disease Therapeutics Market Regional Insights
North America held the largest global infectious disease therapeutics market share in 2021 due to the region's growing rate of infectious diseases. This region's large geriatric population has emerged as a significant growth factor for the market during the forecast period. People's increased disposable income has also become an important growth factor. The government's provision of advanced health-care facilities in the form of reimbursement policies has greatly aided market growth. Moreover, the existence of key manufacturers in the United States, as well as an increase in clinical trials for the introduction of new treatment drugs, are estimated to generate to this region's large market share.
Due to the growing occurrence of infectious diseases and increasing expenditure on the prevention and diagnosis of infectious diseases, Asia Pacific is projected to expand at the fastest CAGR during the forecast period.
Infectious Disease Therapeutics Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
